WCCT Global, a full service CRO head quartered in Southern California announced today that they have been added to the SCRIPT shortlist for possible award of Best Contract Research Organization of 2014. This is a tremendous accomplishment because only 4 finalists were chosen. WCCT Global is being considered for this award for their pursuit of excellence and innovation in early and late phase clinical research and in patient recruitment. Clinical trial management is an area that the Full Service CRO has continued to shine based on multiple successful clinical studies where every aspect of the trial was completed on or before agreed upon milestones. In addition to completing trials on time, the CRO has been focused on innovation by building the only commercial Influenza challenge facility in the United States and has acquired a live strain of the H1N1 influenza virus to conduct the challenge trials. This places WCCT Global as the only commercial CRO in the United States with this capability.
In regards to patient enrollment, WCCT Global over the past 2 years has developed a cutting edge patient recruitment platform called “In-Site” that is designed to give sponsors the assurance of complete enrollment with a risk-free enrollment solution where clients only pay for randomized patients. WCCT Global offers this innovative enrollment solution because they feel a truly full service contract research organization should own every aspect of the clinical trial including enrollment and be held accountable.
WCCT Global’s CEO Dr. Kenneth Kim States, ” I am eager to be in attendance in London for this great achievement. WCCT Global has always strived to be the industry leader in offering our pharmaceutical partners adaptive solutions to exceed their needs. We continually strive to improve clinical research and patient recruitment as a whole.”